Abbonarsi

Wilms tumor screening in diffuse capillary malformation with overgrowth and macrocephaly–capillary malformation: A retrospective study - 27/12/17

Doi : 10.1016/j.jaad.2017.06.014 
Caitlin M. Peterman, BS a, b, c, Sophie Vadeboncoeur, MD b, c, d, John B. Mulliken, MD c, e, Steven J. Fishman, MD c, f, Marilyn G. Liang, MD b, c,
a Tufts University School of Medicine, Boston, Massachusetts 
b Department of Dermatology, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 
c Vascular Anomalies Center, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 
e Department of Plastic and Oral Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 
f Department of Surgery, Boston Children's Hospital, Harvard Medical School, Boston, Massachusetts 
d Department of Medicine, Dermatology Division, Hôpital Maisonneuve-Rosemont, Université de Montréal, Montreal, Quebec, Canada 

Correspondence to: Marilyn G. Liang, MD, Department of Dermatology, Boston Children's Hospital, 300 Longwood Ave, Boston, MA 02115.Department of DermatologyBoston Children's Hospital300 Longwood AveBostonMA02115

Abstract

Background

CLOVES (congenital lipomatous overgrowth, vascular malformations, epidermal nevi, and skeletal anomalies) syndrome is associated with regional bony and/or soft tissue overgrowth, capillary malformation, and an increased risk for Wilms tumor.

Objective

To evaluate the frequency of Wilms tumor in patients with 2 similar conditions: diffuse capillary malformation with overgrowth (DCMO) and macrocephaly–capillary malformation (M-CM).

Methods

Culling our Vascular Anomalies Center database, we retrospectively reviewed patients in whom DCMO and M-CM had been diagnosed and who were evaluated between 1998 and 2016 for possible development of Wilms tumor. Patients younger than 8 years of age at their last visit and not seen in more than 2 years were contacted for follow-up.

Results

The study comprised 89 patients: 67 with DCMO, 17 with M-CM, and 5 with an indeterminate diagnosis. No case of Wilms tumor was found in these groups.

Limitations

Some patients were younger than 8 years of age at last follow-up visit and the sample size was small.

Conclusion

Patients with DCMO do not appear to be at increased risk for Wilms tumor. Screening is probably unnecessary in DCMO unless there is associated hemihypertrophy. Although there were no cases in our cohort, there are 2 reports of M-CM associated with Wilms tumor in the literature.

Il testo completo di questo articolo è disponibile in PDF.

Key words : diffuse capillary malformation, macrocephaly–capillary malformation, overgrowth, Wilms tumor

Abbreviations used : BWS, CLOVES, CM, CVM, DCMO, KTS, M-CM, PROS, WT


Mappa


 Ms Peterman and Dr Vadeboncoeur contributed equally to this work.
 Funding sources: None.
 Conflicts of interest: None declared.
 Preliminary data from this study were presented at the 42nd Annual Meeting of the Society of Pediatric Dermatology, Minneapolis, MN; July 16, 2016.
 Reprints not available from the authors.


© 2017  American Academy of Dermatology, Inc.. Pubblicato da Elsevier Masson SAS. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 77 - N° 5

P. 874-878 - novembre 2017 Ritorno al numero
Articolo precedente Articolo precedente
  • Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas
  • Andre Vadimovich Moyakine, Bjorn Herwegen, Catharina Joanna Maria van der Vleuten
| Articolo seguente Articolo seguente
  • Outpatient dermatology consultation impacts the diagnosis and management of pediatric oncology patients: A retrospective study
  • Hannah Song, Sarah N. Robinson, Jennifer T. Huang

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.